Skip to main content
. 2022 Oct 29;23(21):13146. doi: 10.3390/ijms232113146

Figure 1.

Figure 1

Representative images of normal and malignant prostate cancers, immunostained for ARSB. (A–E). Declines in intensity and in membrane immunostaining are evident, as Gleason score increases from 6 to 9 [42].